Genzyme (GENZ) Reports In-Line Q2; Cuts Guidance

July 22, 2009 9:06 AM EDT Send to a Friend

Genzyme Corp. (Nasdaq: GENZ) reports Q2 EPS of $0.85, in-line with estimates ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Genzyme (GENZ) Reports In-Line Q2; Cuts Guidance

Member Login

Free News Feed